Review



c kluyveri dsm 555  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC c kluyveri dsm 555
    C Kluyveri Dsm 555, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 727 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c kluyveri dsm 555/product/ATCC
    Average 96 stars, based on 727 article reviews
    c kluyveri dsm 555 - by Bioz Stars, 2026-05
    96/100 stars

    Images



    Similar Products

    96
    ATCC c kluyveri dsm 555
    C Kluyveri Dsm 555, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c kluyveri dsm 555/product/ATCC
    Average 96 stars, based on 1 article reviews
    c kluyveri dsm 555 - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    97
    PCR Biosystems Ltd ◦ c qpcr
    ◦ C Qpcr, supplied by PCR Biosystems Ltd, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/◦ c qpcr/product/PCR Biosystems Ltd
    Average 97 stars, based on 1 article reviews
    ◦ c qpcr - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    96
    R&D Systems c r d systems cat 219 il 005 final conc 40 ng ml
    C R D Systems Cat 219 Il 005 Final Conc 40 Ng Ml, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c r d systems cat 219 il 005 final conc 40 ng ml/product/R&D Systems
    Average 96 stars, based on 1 article reviews
    c r d systems cat 219 il 005 final conc 40 ng ml - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology lgr4 antibody c 12 alexa fluor 647
    Lgr4 Antibody C 12 Alexa Fluor 647, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lgr4 antibody c 12 alexa fluor 647/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    lgr4 antibody c 12 alexa fluor 647 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    95
    Bio X Cell catalog be0051 storage conditions 4° c vehicle sterile pbs formulation stability prepare fresh daily dose 0 625 mg mouse
    Catalog Be0051 Storage Conditions 4° C Vehicle Sterile Pbs Formulation Stability Prepare Fresh Daily Dose 0 625 Mg Mouse, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog be0051 storage conditions 4° c vehicle sterile pbs formulation stability prepare fresh daily dose 0 625 mg mouse/product/Bio X Cell
    Average 95 stars, based on 1 article reviews
    catalog be0051 storage conditions 4° c vehicle sterile pbs formulation stability prepare fresh daily dose 0 625 mg mouse - by Bioz Stars, 2026-05
    95/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc ◦c with pak3
    ◦C With Pak3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/◦c with pak3/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    ◦c with pak3 - by Bioz Stars, 2026-05
    93/100 stars
      Buy from Supplier

    96
    InvivoGen poly i c
    A-L. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. A-B. IFN-β and IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment. n = 3. **** = p < 0.0001. Two-way ANOVA followed by Tukey’s post hoc multiple comparisons test. C-L. Protein lysates were probed for phosphorylated IRF3 (Ser386 or Ser396), total IRF3, phosphorylated TBK1 (Ser172), total TBK1, and β-actin as a loading control. As a positive control for IRF3 and TBK1 activation/phosphorylation, A549 cells were treated with 7 μg/mL <t>poly(I:C)</t> for 6 and 48 hours before protein lysates were collected. Protein was isolated from treated BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i ( C-G ) or lytic+casp-i+anti-IFN Abs ( H-L ) sample based on tdTomato expression. Western blot for phosphorylated TBK1 and phosphorylated IRF3 for bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples and sorted tdTomato+ and tdTomato- samples were quantified by normalizing the density of phosphorylated protein to unphosphorylated protein bands. Phosphorylation levels are plotted relative to the bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples. M. KSHV-negative BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3 (Ser386), and total IRF3. Images shown are representative of 3 replicates. None of the differences in quantified levels are statistically significant based on one-way ANOVA followed by Tukey’s post hoc multiple comparisons test (D-E, G, I-J, L).
    Poly I C, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/poly i c/product/InvivoGen
    Average 96 stars, based on 1 article reviews
    poly i c - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    96
    InvivoGen i c lyovec tm
    A-L. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. A-B. IFN-β and IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment. n = 3. **** = p < 0.0001. Two-way ANOVA followed by Tukey’s post hoc multiple comparisons test. C-L. Protein lysates were probed for phosphorylated IRF3 (Ser386 or Ser396), total IRF3, phosphorylated TBK1 (Ser172), total TBK1, and β-actin as a loading control. As a positive control for IRF3 and TBK1 activation/phosphorylation, A549 cells were treated with 7 μg/mL <t>poly(I:C)</t> for 6 and 48 hours before protein lysates were collected. Protein was isolated from treated BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i ( C-G ) or lytic+casp-i+anti-IFN Abs ( H-L ) sample based on tdTomato expression. Western blot for phosphorylated TBK1 and phosphorylated IRF3 for bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples and sorted tdTomato+ and tdTomato- samples were quantified by normalizing the density of phosphorylated protein to unphosphorylated protein bands. Phosphorylation levels are plotted relative to the bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples. M. KSHV-negative BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3 (Ser386), and total IRF3. Images shown are representative of 3 replicates. None of the differences in quantified levels are statistically significant based on one-way ANOVA followed by Tukey’s post hoc multiple comparisons test (D-E, G, I-J, L).
    I C Lyovec Tm, supplied by InvivoGen, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/i c lyovec tm/product/InvivoGen
    Average 96 stars, based on 1 article reviews
    i c lyovec tm - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology c 12 wb
    A-L. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. A-B. IFN-β and IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment. n = 3. **** = p < 0.0001. Two-way ANOVA followed by Tukey’s post hoc multiple comparisons test. C-L. Protein lysates were probed for phosphorylated IRF3 (Ser386 or Ser396), total IRF3, phosphorylated TBK1 (Ser172), total TBK1, and β-actin as a loading control. As a positive control for IRF3 and TBK1 activation/phosphorylation, A549 cells were treated with 7 μg/mL <t>poly(I:C)</t> for 6 and 48 hours before protein lysates were collected. Protein was isolated from treated BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i ( C-G ) or lytic+casp-i+anti-IFN Abs ( H-L ) sample based on tdTomato expression. Western blot for phosphorylated TBK1 and phosphorylated IRF3 for bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples and sorted tdTomato+ and tdTomato- samples were quantified by normalizing the density of phosphorylated protein to unphosphorylated protein bands. Phosphorylation levels are plotted relative to the bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples. M. KSHV-negative BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3 (Ser386), and total IRF3. Images shown are representative of 3 replicates. None of the differences in quantified levels are statistically significant based on one-way ANOVA followed by Tukey’s post hoc multiple comparisons test (D-E, G, I-J, L).
    C 12 Wb, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c 12 wb/product/Santa Cruz Biotechnology
    Average 94 stars, based on 1 article reviews
    c 12 wb - by Bioz Stars, 2026-05
    94/100 stars
      Buy from Supplier

    Image Search Results


    A-L. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. A-B. IFN-β and IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment. n = 3. **** = p < 0.0001. Two-way ANOVA followed by Tukey’s post hoc multiple comparisons test. C-L. Protein lysates were probed for phosphorylated IRF3 (Ser386 or Ser396), total IRF3, phosphorylated TBK1 (Ser172), total TBK1, and β-actin as a loading control. As a positive control for IRF3 and TBK1 activation/phosphorylation, A549 cells were treated with 7 μg/mL poly(I:C) for 6 and 48 hours before protein lysates were collected. Protein was isolated from treated BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i ( C-G ) or lytic+casp-i+anti-IFN Abs ( H-L ) sample based on tdTomato expression. Western blot for phosphorylated TBK1 and phosphorylated IRF3 for bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples and sorted tdTomato+ and tdTomato- samples were quantified by normalizing the density of phosphorylated protein to unphosphorylated protein bands. Phosphorylation levels are plotted relative to the bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples. M. KSHV-negative BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3 (Ser386), and total IRF3. Images shown are representative of 3 replicates. None of the differences in quantified levels are statistically significant based on one-way ANOVA followed by Tukey’s post hoc multiple comparisons test (D-E, G, I-J, L).

    Journal: PLOS Pathogens

    Article Title: Interferon-β induction heterogeneity during KSHV infection is correlated to levels and activation of the transcription factors ATF2 and RelA, and not IRF3

    doi: 10.1371/journal.ppat.1013947

    Figure Lengend Snippet: A-L. BC3-IFN-βp-tdTomato reporter cells were treated with 20 ng/ml TPA for 48 hours to induce the lytic cycle (“lytic (+TPA)”). Where indicated, the cells were also treated with 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”), 10 μM of the TBK1 inhibitor MRT76307 (“TBK1i”), 10 μM of the cGAS inhibitor G140 (“cGASi”), and/or a cocktail of antibodies against type I IFNs and their receptor (“anti-IFN Abs”) at 1:2000 dilution. A-B. IFN-β and IFN-λ1 mRNA levels were measured by qRT-PCR and normalized to 18S rRNA. The expression levels are plotted relative to lytic+casp-i samples that did not receive TBK1i or cGASi treatment for each experiment. n = 3. **** = p < 0.0001. Two-way ANOVA followed by Tukey’s post hoc multiple comparisons test. C-L. Protein lysates were probed for phosphorylated IRF3 (Ser386 or Ser396), total IRF3, phosphorylated TBK1 (Ser172), total TBK1, and β-actin as a loading control. As a positive control for IRF3 and TBK1 activation/phosphorylation, A549 cells were treated with 7 μg/mL poly(I:C) for 6 and 48 hours before protein lysates were collected. Protein was isolated from treated BC3-IFN-βp-tdTomato reporter cells without sorting (“bulk”), or after sorting the lytic+casp-i ( C-G ) or lytic+casp-i+anti-IFN Abs ( H-L ) sample based on tdTomato expression. Western blot for phosphorylated TBK1 and phosphorylated IRF3 for bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples and sorted tdTomato+ and tdTomato- samples were quantified by normalizing the density of phosphorylated protein to unphosphorylated protein bands. Phosphorylation levels are plotted relative to the bulk lytic+casp-i or lytic+casp-i+anti-IFN Abs treated samples. M. KSHV-negative BJAB cells were treated with vehicle, 20 ng/ml TPA, and/or 10 μM of the pan-caspase inhibitor IDN-6556 (“casp-i”) for 48 hours. Protein was isolated and stained for phosphorylated TBK1, total TBK1, phosphorylated IRF3 (Ser386), and total IRF3. Images shown are representative of 3 replicates. None of the differences in quantified levels are statistically significant based on one-way ANOVA followed by Tukey’s post hoc multiple comparisons test (D-E, G, I-J, L).

    Article Snippet: Where indicated, A549 cells were seeded at 0.5x10 cells per well in a 6-well plate 1 day before treatment, and treated with vehicle (water) or 7 μg/mL poly(I:C) (poly(I:C) LMW/ LyoVec, Invivogen, TLRLPICWLV) for 6 or 48 hours.

    Techniques: Quantitative RT-PCR, Expressing, Control, Positive Control, Activation Assay, Phospho-proteomics, Isolation, Western Blot, Staining